The IL-2 level was significantly and negatively correlated with the rate of disease progression in patients with ALS and positively correlated with cortical thickness in the right lingual region, suggesting that IL-2 is protective in these patients and that IL-2 biologics may be used in the treatment of ALS. This evidence concerns the gene IL2 and amyotrophic lateral sclerosis.